·
1 Min Read

AMA applauds congressional action on prescription drug transparency

The AMA believes in transparency in prescription drug pricing, and we are pleased the House Ways & Means Committee moved the issue forward.

Press Releases
Graphic image of pill bottles with different money signs on them.
·
3 Min Read

How are prescription drug prices determined?

Congress has put drug prices under its microscope. The scrutiny is new, but the conversation is the same: Drugmakers, pharmacy benefit managers and payers set prices but never explain how.

Behavioral Health
Pill bottle being filled
·
2 Min Read

Quick Take: Action on drug pricing gets massive bipartisan support

Legislation to speed generic drugs to market, improving price transparency and boost competition could soon come to the House floor.

Behavioral Health
·
5 Min Read

March 21, 2019: State Advocacy Update

NCOIL & drug price transparency and rural Missouri pain & addiction treatment in the latest AMA state and local advocacy efforts.

Advocacy Update
·
5 Min Read

Feb. 22, 2019: National Advocacy Update

HHS proposed rule on drug rebates, the House and gun violence and more in the latest from AMA national advocacy news.

Advocacy Update
·
7 Min Read

Feb. 7, 2019: National Advocacy Update

Step therapy & pharmaceuticals limiting, youth tobacco use and more in the latest AMA national advocacy update.

Advocacy Update
·
2 Min Read

Jan. 10, 2019: Advocacy spotlight on Issues to watch in the 116th Congress

Issues to watch in the 116th Congress: AMA on ACA, prescription drug prices and more.

Advocacy Update
·
11 Min Read

Jan. 10, 2019: National Advocacy Update

Physicians comment on Part B drug payment proposal, Trump Administration's H-1B proposed rule, and more in AMA's national advocacy news.

Advocacy Update
·
6 Min Read

Dec. 13, 2018: National Advocacy Update

Choice and competition in health care, new drug pricing rule for Part D drugs and more in AMA's national advocacy news.

Advocacy Update